フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
MediPharm Labs to Sell its Napanee Facility to Kensana Health for $5.5M PR Newswire TORONTO, Dec. 17, 2024...
MediPharm Labs Reports Third Quarter Results PR Newswire TORONTO, Nov. 14, 2024 Strong Growth in International...
MediPharm Labs Sets Date to Report Third Quarter 2024 Financial Results PR Newswire TORONTO, Nov. 11, 2024...
MediPharm Labs Announces Departure of President and Co-Founder Keith Strachan PR Newswire TORONTO, Oct. 17...
MediPharm Labs Announces $2.1M Debt Repayment PR Newswire TORONTO, Sept. 17, 2024 Company Now Materially Debt...
MediPharm Labs Reports Second Quarter Results Closing in on Positive Adjusted EBITDA(1) as Gross Profit...
/R E P E A T -- MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results/ PR Newswire TORONTO...
MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results PR Newswire TORONTO, Aug. 8, 2024...
MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders PR Newswire TORONTO, June...
MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols PR Newswire TORONTO, June 20, 2024 MediPharm...
MediPharm Labs Reports First Quarter Results PR Newswire TORONTO, May 15, 2024 Completes Major Steps Towards...
MediPharm Labs Sets Date to Report First Quarter 2024 Financial Results PR Newswire TORONTO, May 8, 2024...
MediPharm Labs Provides Conference Call Recording Details PR Newswire TORONTO, March 27, 2024 TORONTO, March...
MediPharm Labs Reports Fourth Quarter and Full Year Results PR Newswire TORONTO, March 27, 2024 Annual Revenue...
MediPharm Labs Provides Update on German Cannabis Legalization PR Newswire TORONTO, March 25, 2024 German...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約